Adage Capital Partners Gp, L.L.C. Tenaya Therapeutics, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.6 Billion
- Q3 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 324,245 shares of TNYA stock, worth $1.16 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
324,245
Previous 1,000,000
67.58%
Holding current value
$1.16 Million
Previous $3.1 Million
79.84%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding TNYA
# of Institutions
96Shares Held
56.3MCall Options Held
900Put Options Held
400-
Column Group LLC San Francisco, CA9.4MShares$33.7 Million26.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.98MShares$25 Million0.19% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$24.1 Million1.01% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$14.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$11.5 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $148M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...